JNBYF yields 11.67% · MRK yields 2.76%● Live data
📍 JNBYF pulled ahead of the other in Year 1
Combined, JNBYF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JNBYF + MRK for your $10,000?
JNBY Design Limited, together with its subsidiaries, engages in the design, marketing, retail, and sale of fashion apparels, accessory products, and household goods in the People's Republic of China and internationally. It offers contemporary apparel, footwear, and accessories for women, men, and children, as well as household products under the JNBY, CROQUIS, jnby by JNBY, LESS, POMME DE TERRE, and JNBYHOME brands. As of June 30, 2022, the company operated 1,956 retail stores. It also offers its products through online and social media interactive marketing service platforms. The company was formerly known as Croquis Investment Limited and changed its name to JNBY Design Limited in June 2016. JNBY Design Limited was founded in 1994 and is headquartered in Hangzhou, the People's Republic of China.
Full JNBYF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.